Cardiovascular Systems Return on Investment 2006-2018 | CSII

Current and historical return on investment (ROI) values for Cardiovascular Systems (CSII) over the last 10 years.
Cardiovascular Systems ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2018-12-31 $0.00B $0.16B 0.65%
2018-09-30 $0.00B $0.16B 0.66%
2018-06-30 $0.00B $0.16B 1.36%
2018-03-31 $-0.00B $0.15B -0.70%
2017-12-31 $-0.00B $0.15B -2.15%
2017-09-30 $-0.00B $0.14B -1.52%
2017-06-30 $-0.00B $0.14B -1.64%
2017-03-31 $-0.01B $0.13B -7.11%
2016-12-31 $-0.03B $0.11B -27.75%
2016-09-30 $-0.05B $0.10B -42.15%
2016-06-30 $-0.06B $0.10B -49.23%
2016-03-31 $-0.06B $0.10B -48.68%
2015-12-31 $-0.05B $0.12B -35.96%
2015-09-30 $-0.04B $0.13B -27.09%
2015-06-30 $-0.03B $0.14B -22.84%
2015-03-31 $-0.03B $0.14B -23.01%
2014-12-31 $-0.03B $0.15B -21.85%
2014-09-30 $-0.04B $0.15B -22.88%
2014-06-30 $-0.03B $0.15B -25.42%
2014-03-31 $-0.03B $0.16B -27.13%
2013-12-31 $-0.03B $0.16B -27.37%
2013-09-30 $-0.02B $0.07B -36.36%
2013-06-30 $-0.02B $0.07B -37.61%
2013-03-31 $-0.02B $0.08B -37.07%
2012-12-31 $-0.02B $0.04B -45.28%
2012-09-30 $-0.02B $0.04B -43.59%
2012-06-30 $-0.02B $0.05B -40.82%
2012-03-31 $-0.01B $0.03B -36.36%
2011-12-31 $-0.01B $0.04B -32.00%
2011-09-30 $-0.01B $0.03B -27.83%
2011-06-30 $-0.01B $0.03B -36.73%
2011-03-31 $-0.01B $0.03B -50.53%
2010-12-31 $-0.02B $0.03B -73.56%
2010-09-30 $-0.02B $0.02B -101.20%
2010-06-30 $-0.02B $0.03B -96.84%
2010-03-31 $-0.03B $0.02B -97.09%
2009-12-31 $-0.03B $0.02B -84.03%
2009-09-30 $-0.02B $0.03B -75.00%
2009-06-30 $-0.03B $0.04B -91.23%
2009-03-31 $-0.04B $0.03B -197.47%
2008-12-31 $-0.04B $0.00B -142.37%
2008-09-30 $-0.04B $0.05B -142.37%
2008-06-30 $-0.04B $0.00B -97.67%
2008-03-31 $0.03B $0.07B 46.81%
2007-12-31 $0.03B $0.00B 47.06%
2007-09-30 $0.03B $0.10B 47.06%
2007-06-30 $0.04B $0.11B 61.66%
2007-03-31 $-0.03B $0.06B -54.35%
2006-12-31 $-0.02B $0.00B -76.03%
2006-09-30 $-0.02B $0.08B -52.57%
2006-06-30 $-0.02B $0.04B -101.05%
2006-03-31 $-0.02B $0.00B -170.37%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.190B $0.217B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
Canopy Growth (CGC) Canada $14.912B 0.00
ResMed (RMD) United States $14.218B 26.96
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Insulet (PODD) United States $4.900B 1642.60
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
Neogen (NEOG) United States $2.958B 48.10
NuVasive (NUVA) United States $2.784B 24.18
Quidel (QDEL) United States $2.365B 21.17
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
HEXO (HEXO) $1.424B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.88
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71